| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mean background count : DPM THE LOCAL LYMPH NODE ASSAY - STUDY NUMBER | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rack/Sample Position | Sample Description | No. Lymph Nodes | Sample DPM |
Expression and interpretation of results
Test substance :
Sample ref. no. :
Exposure period (days) :
The proliferative response of lymph node cells (LNC) is expressed as the number of radioactive disintergrations per minute per lymph node (DPM/NODE) and as the ration of 3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (TEST/CONTROL RATIO). The test substance can be regarded as a 'sensitizer' if at least one test concentration produces a test/control ration equal to or greater than 3.0. The data must also be compatible with a biological dose response, although allowance must be made, especially at high topical application concentrations, for local toxicity and/or immunological suppression. Where the data does not fulfill these criteria, the test substance can be regarded as 'unlikely to be a strong sensitizer'.
Background count : DPM
| Sample Description | Sample DPM - Background DPM | No. Lymph Nodes | DPM/NODE | TEST/CONTROL RATIO | +/- |
Biological dose response - Yes/No.
Comments:
Control raw data retrieved from the ?-scintillation counter
Results:
3
HTdR incorporation into control LNC determined days after the first vehicle topical application.
?-Counter printout inserted here
| Rack/Sample Position | Sample Description | No. Lymph Nodes | Sample DPM |
Mean background count : DPM
Test raw data retrieved from ?-scintillation counter
Test substance :
Sample ref. no. :
3HTdR incorporation into test LNC determined days after the first test substance topical applications.
Results:
?-Counter printout inserted here
| Rack/Sample Position | Sample Description | No. Lymph Nodes | Sample DPM |
Expression and interpretation of results
Test substance :
Sample ref. no. :
Exposure period (days) :
The proliferative response of lymph node cells (LNC) is expressed as the number of radioactive disintergrations per minute per lymph node (DPM/NODE) and as the ration of 3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (TEST/CONTROL RATIO). The test substance can be regarded as a 'sensitizer' if at least one test concentration produces a test/control ration equal to or greater than 3.0. The data must also be compatible with a biological dose response, although allowance must be made, especially at high topical application concentrations, for local toxicity and/or immunological suppression. Where the data does not fulfill these criteria, the test substance can be regarded as 'unlikely to be a strong sensitizer'.
Background count : DPM
| Sample Description Test or Control Group | Group Mean DPM | Group Mean Standard Error | TEST/CONTROL RATIO | +/- |
Biological dose response - Yes/No.
Comments:
Mouse maintenance, treatment record, and task sheet
Strain : CBA/_____
Sex : Female
Age :
Source :
Diet :
Water : Ad libitum
Housing :
Test substance :
Sample ref. no. :
| Animal Group | Topical Application | Admin. of 3HTdR | Mice Killed | Processing Nodes | Samples Counted | ||||
| Day 0 | Day 1 | Day 2 | No. Mice Injured | No. Nodes Excised | |||||
More information concerning animal maintenance (including diet batch numbers) are detailed on the 'Animal Log' sheet recorded separately from this study.
Comments:
Tools | ||||||
|
MeetingS |
Workshop: Lessons Learned, Challenges, and Opportunities: The US Endocrine Disruptor Screening Program Developing Microphysiological Systems for Use as Regulatory Tools- Challenges and Opportunities Advances in In Vitro Cell and Tissue Culture Joint US Workshop: Scientific Roadmap for the Future of Animal-Free Systemic Toxicity Testing International Congress of Toxicology EUSAAT's 2013 Congress and Symposium LATINFARMA 2013: 3Rs Alternatives in Pharmacology, Toxicology and Teaching Workshop In Vitro Medical Device Testing Symposium |